# Safar Partners

> Safar Partners is a VC fund backing Biotechnology and Health Care. See 92 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Cambridge, United States
- Total investments: 92
- Last investment: Jul 2026
- Lead investor: 21%
- Fund size: $192M
- Last fund: May 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/safar-partners/
- Website: https://safar.partners/

Safar Partners is a seed- to growth-stage venture fund investing primarily in technology companies out of MIT, Harvard, and the University of Rochester. We invest in platform technologies in the cleantech and advanced materials, AI/IT and robotics, and life science/medical device areas.

## Contacts

5 contacts available for Safar Partners. Shizune tracks 3 team members at Safar Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/safar-partners-7ab4?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.5M–$38M |
| Series A | $11M–$84M |
| Series B | $7M–$863M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 11 | 12% |
| Health Care | 9 | 10% |
| Information Technology | 8 | 9% |
| Manufacturing | 7 | 8% |
| Medical | 6 | 7% |

91 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 21 | 23% |
| Series A | 17 | 18% |
| Series B | 14 | 15% |
| Venture - Series Unknown | 9 | 10% |
| Funding Round | 7 | 8% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 54 | 59% |
| China | 1 | 1% |
| Italy | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Arunas Chesonis | Managing Partner & Investment Committee Member | 14 | https://shizune.co/investors/profile/arunas-chesonis |
| Nader Motamedy | Founder & Managing Partner | 7 | https://shizune.co/investors/profile/nader-motamedy-ab57 |
| Vera Schroeder | Associate | 2 | https://shizune.co/investors/profile/vera-schroeder |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EELI Technology | EELI Technology Inc., a Silicon Valley–based critical minerals technology company, enables lithium production from sources once considered impossible to mine economically —cheaper, faster, electrified. | $2M | Pre-Seed | Jul 21, 2026 |  |
| Quaise Energy | Quaise is an energy company that is developing and commercializing novel millimeter-wave drilling systems to harness geothermal energy around the globe, overcoming the geographic constraints limiting this energy source today. The company was founded in 2018 and is based in Cambridge, Massachusetts. | $134.1M | Series B | Jul 07, 2026 |  |
| Quaise Energy | Quaise is an energy company that is developing and commercializing novel millimeter-wave drilling systems to harness geothermal energy around the globe, overcoming the geographic constraints limiting this energy source today. The company was founded in 2018 and is based in Cambridge, Massachusetts. | $134.1M | Series B | Jul 07, 2026 |  |
| Gradiant | Gradiant is a solutions provider and developer of cleantech water projects for advanced water and wastewater treatment. They provide microelectronics, pharmaceuticals, food and beverage, lithium and key minerals, and renewable energy. |  | Series E | May 18, 2026 |  |
| Via Separations | Via Separations is enabling industrial decarbonization with its novel chemistries that allow manufacturing facilities to slash their energy consumption while making more product. Targeting the 12% of US energy consumption that is wasted each year separating chemicals, Via reduces the load of the process by 90%, electrifies the mostenergy-intensive step in chemical production, and generates additional revenue for the customer. Today, Via is deploying its technology in pilot trials at pulp & paper facilities to eliminate 100 million metric tons of CO2 by 2050. Via’s innovation is a highly selective and robust membrane filter that replaces the energy-inefficient heat-based separations in industrial processes. Spun out of MIT’s Department of Material Science & Engineering, Via has scaled up the technology by more than 10 million times and demonstrated working prototypes at a commercial scale. | $36M | Venture - Series Unknown | Apr 01, 2026 |  |
| Gelmedix | Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients. | $13M | Seed | Feb 17, 2026 |  |
| Gelmedix | Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients. | $13M | Seed | Feb 17, 2026 |  |
| Alva Energy | Alva Energy specializes in nuclear plant upgrades called "uprates" to boost clean power output from existing U.S. reactors. It standardizes complex retrofits into repeatable, turnkey projects for faster and cheaper deployment. | $33M | Series A | Feb 12, 2026 |  |
| Zanskar | Zanskar develops a predictive platform informed by massive data for discovering previously unknown geothermal resources. Its platform includes subsurface characterization technology and massive data sets, enhancing and reducing risk in the exploration of geothermal resources. | $115M | Series C | Jan 21, 2026 |  |
| DMAT | DMAT develops highly-advanced concrete formulas that increase durability and reduce carbon emissions. Our mission is to bring a new level of sustainability and innovation to the concrete industry. | $4.5M | Seed | Oct 21, 2025 |  |

10 of 92 investments shown.

## Co-investors
- [The Engine](https://shizune.co/investors/profile/the-engine) — VC Fund, 9 deals together
- [The Engine](https://shizune.co/investors/profile/the-engine-b5c2) — VC Fund, 9 deals together
- [Lowercarbon Capital](https://shizune.co/investors/profile/lowercarbon-capital) — VC Fund, 6 deals together
- [Fine Structure Venture](https://shizune.co/investors/profile/fine-structure-venture) — VC Fund, 5 deals together
- [Hostplus](https://shizune.co/investors/profile/hostplus) — VC Fund, 5 deals together
- [Prelude Ventures](https://shizune.co/investors/profile/prelude-ventures-llc) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Manufacturing Investors in United States](https://shizune.co/investors/manufacturing-investors-united-states)
- [Manufacturing VC Funds in United States](https://shizune.co/investors/manufacturing-vc-funds-united-states)
- [Sustainability Investors in United States](https://shizune.co/investors/sustainability-investors-united-states)
- [Sustainability VC Funds in United States](https://shizune.co/investors/sustainability-vc-funds-united-states)
- [Impact Investors in United States](https://shizune.co/investors/impact-investors-united-states)
- [Impact VC Funds in United States](https://shizune.co/investors/impact-vc-funds-united-states)

## FAQ

### What does Safar Partners invest in?

Safar Partners invests primarily in Biotechnology, Health Care and Information Technology startups, most often at Seed and Series A stage. Most of the 92 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Safar Partners's check size?

Safar Partners typically joins rounds of $1.5M–$38M at Seed, $11M–$84M at Series A and $7M–$863M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Safar Partners participates in.

### How do I contact Safar Partners?

Public channels for Safar Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Safar Partners?

The team at Safar Partners includes Arunas Chesonis (Managing Partner & Investment Committee Member), Nader Motamedy (Founder & Managing Partner) and Vera Schroeder (Associate). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co